Skip to content
Curis logo

Curis Alternatives & Competitors

12 companies similar to Curis — Working relentlessly to develop innovative and differentiated therapeutics that...

Companies similar to Curis

Flare Therapeutics logo — alternative to Curis

Flare Therapeutics

Trailblazing the path to drugging transcription factors to discover precision medicines fo...

Apollomics logo — alternative to Curis

Apollomics

We are a biopharmaceutical company committed to the discovery and development of mono- and...

Agennix logo — alternative to Curis

Agennix

Crafting novel therapies to enhance the length and quality of life for seriously ill patie...

Redx Pharma logo — alternative to Curis

Redx Pharma

Biotech company focusing on the discovery and development of novel targeted medicines to t...

Rival Readout

Competing with Curis? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Pacylex Pharmaceuticals, Inc. logo — alternative to Curis

Pacylex Pharmaceuticals, Inc.

A new target in cancer care - triggering selective lethality with a new class of drugs.

Arcus Biosciences logo — alternative to Curis

Arcus Biosciences

Biopharmaceutical company developing differentiated molecules and combination therapies fo...

Synta Pharmaceuticals logo — alternative to Curis

Synta Pharmaceuticals

Innovating patient care with advanced small molecule therapies for severe medical conditio...

Inspirna, Inc. logo — alternative to Curis

Inspirna, Inc.

Converting cancer to a manageable, chronic condition

FibroGen, Inc. logo — alternative to Curis

FibroGen, Inc.

Committed to being a place where our people and science thrive.

Cascadian Therapeutics, Inc. logo — alternative to Curis
Tarveda Therapeutics logo — alternative to Curis

Tarveda Therapeutics

To discover, develop and commercialize a new class of potent and selective precision oncol...

Scorpion Therapeutics logo — alternative to Curis

Scorpion Therapeutics

Pioneering the Next Generation of Precision Oncology

About Curis

Curis, a publicly-traded biotechnology company (NASDAQ: CRIS), focuses on developing first-in-class and innovative therapeutics for cancer treatment. The company has three drug candidates in development: Emavusertib (CA-4948), CI-8993, and Fimepinostat. It also collaborates with Aurigene for immuno-oncology and precisi...

Business keywords

Oncology, Drug Development, Immunology, Clinical Development, Hematology, Therapeutics, Cancer Treatment, Small Molecule Inhibitors, Monoclonal Antibodies, Precision Oncology, Signal Pathway Drug Technologies, Collaborative Research, Publicly-Traded Company, Biomolecular Research

Frequently Asked Questions

Companies similar to Curis include Flare Therapeutics, Apollomics, Agennix, Redx Pharma, Pacylex Pharmaceuticals, Inc.. They work in Biotechnology and Health Care and share Curis's focus on cancer treatment, drug development and oncology.
Bounce Watch lists 12 companies that share Curis's industries and are closest to it in business tags, services, target customers, business model and size.
Curis, a publicly-traded biotechnology company (NASDAQ: CRIS), focuses on developing first-in-class and innovative therapeutics for cancer treatment. The company has three drug candidates in development: Emavusertib (CA-4948), CI-8993, and Fimepinostat. It also collaborates with Aurigene for immuno-oncology and precisi...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Curis: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Curis on 9 Nov 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout